The GUARDIAN (Genomic Uniform-screening Against Rare Diseases In All Newborns) study offers genomic newborn screening to babies born in 6 New York City hospitals, expanding the number of conditions screened by traditional newborn screening methods. Of the first 4,000 newborns enrolled, 3.7% had positive screenings. The majority of those would not have been picked up by traditional newborn screening today.